Drug Shortage Report for AZARGA

Last updated on 2018-07-27 History
Report ID 54440
Drug Identification Number 02331624
Brand name AZARGA
Common or Proper name AZARGA OPH SUSP 5ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) TIMOLOL BRINZOLAMIDE
Strength(s) 0.5% 1.0%
Dosage form(s) SUSPENSION
Route of administration OPHTHALMIC
Packaging size 5ML
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-06-25
Estimated end date 2018-07-25
Actual end date 2018-07-25
Shortage status Resolved
Updated date 2018-07-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2018-07-27 French Compare
v7 2018-07-27 English Compare
v6 2018-07-20 French Compare
v5 2018-07-20 English Compare
v4 2018-07-11 French Compare
v3 2018-07-11 English Compare
v2 2018-07-05 French Compare
v1 2018-07-05 English Compare

Showing 1 to 8 of 8